Drug Database
Back to search

Japan· JP-3111003S1039

レチノールパルミチン酸エステル

A retinol (vit a) product containing レチノールパルミチン酸エステル, registered in Japan by アルフレッサファーマ, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.

On Japan’s NHI price listATC A11CA01

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedレチノールパルミチン酸エステルATCA11CA01REGISTER NO.JP-3111003S1039PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about レチノールパルミチン酸エステルAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Retinol (vit a) is registered in 5 of 19 countries.

Countries holding a registration under ATC A11CA01 (retinol (vit a)), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 4 of them publish a price we can compare per daily dose
Search retinol (vit a) products by name

Retinol (vit a) · ATC A11CA01

5 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Japan
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
レチノールパルミチン酸エステル
Manufacturer
アルフレッサファーマ
Country
Japan (JP)
ATC code
A11CA01
ATC class
Retinol (vit A)
Defined daily dose
50 TSD, E
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for retinol (vit a).

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check retinol (vit a) against other medicinesHow interaction checks work

Retinol (vit a) · interactions on record

1 record

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under A11CA01

Retinol (vit a), as other registers publish it.

All retinol (vit a) products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f014af0c-99b3-4bcf-8049-c1a8d58072b3
GET /v1/drugs/f014af0c-99b3-4bcf-8049-c1a8d58072b3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "３０，０００単位１ｍＬ",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3111003S1039",
  "category": "内用薬",
  "price_yen": 208.8,
  "generic_name": "レチノールパルミチン酸エステル",
  "product_name_jp": null,
  "therapeutic_class": "3111",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about retinol (vit a).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console